Skip to main content

Table 3 Risk of recurrence within 3 years* estimated by Cox proportional hazard ratio model

From: Postoperative leukopenia after cytoreductive surgery and hypertherm intraperitoneal chemotherapy for colorectal carcinomatosis– causes and implication on outcomes in a population-based study

 

Missing

In analysis,

Univariate analysis

p-value

Multivariate analysis

p-value

data, n

n

HR (95% CI)

 

HR (95% CI)

 

Age:

48

     

 < 65 years

 

292

ref.

   

 ≥ 65 years

 

244

1.039 (0.846–1.276)

0.718

  

Sex:

46

     

 Male

 

246

1.036 (0.844–1.273)

0.739

  

 Female

 

292

ref.

   

Neoadjuvant chemo:

166

     

 Yes

 

125

1.323 (1.031–1.699)

0.028

1.319 (1.019–1.708)

0.036

 No

 

293

ref.

   

Any complication:

51

     

 Yes

 

305

1.081 (0.877–1.333)

0.464

  

 No

 

228

ref.

   

Severe complication:

34

     

 Yes

 

68

1.037 (0.765–1.406)

0.814

  

 No complication

 

228

ref.

   

 Not in analysis (C-D 1-3a)

 

254

    

Duration of surgery:

64

     

 < 480 min

 

271

ref.

   

 ≥ 480 min

 

249

1.117 (0.910–1.370)

0.291

  

Postop leukopenia:

44

     

 Yes

 

51

0.962 (0.676–1.369)

0.83

0.890 (0.586–1.351)

0.585

 No

 

489

ref.

   

Severe leukopenia:

43

     

 Yes

 

30

0.953 (0.670–1.356)

0.789

  

 No

 

489

ref.

   

 Not in analysis (mild leukopenia)

22

    

PCI-score:

48

     

 0–8

 

265

ref.

 

ref.

 

 9–15

 

157

1.664 (1.310–2.115)

< 0.001

1.452 (1.096–1.922)

0.09

 > 15

 

114

1.609 (1.242–2.084)

< 0.001

1.497 (1.093–2.050)

0.012

pN-stage:

68

     

 N0

 

106

ref.

 

ref.

 

 N1

 

183

1.961 (1.421–2.704)

< 0.001

1.908 (1.300-2.799)

< 0.001

 N2

 

224

2.285 (1.672–3.123)

< 0.001

2.523 (1.743–3.653)

< 0.001

 Nx

 

3

    

Period of surgery:

44

     

 2019–2021

 

198

ref.

 

ref.

 

 2016–2018

 

221

0.881 (0.698–1.112)

0.287

0.906 (0.678–1.210)

0.504

 2013–2015

 

100

0.726 (0.542–0.972)

0.031

0.680 (0.478–0.969)

0.033

 ≤ 2012

 

21

0.515 (0.262–1.112)

0.055

0.282 (0.111–0.714)

0.008

  1. * 90 day mortality excluded (n = 12)